-
-
arkk completed the QOL survey for Jan 30, 2012 • Jan 30, 2012- Updated outcome
- QOL
- Good Social
- Bad Mental
- Good Physical
-
-
arkk added a treatment evaluation for Tysabri from Sep 15, 2011 • Jan 30, 2012- New evaluation
- Tysabri Treatment Evaluation
- Efficacy for Other:
- Efficacy for MS (Multiple Sclerosis):
- Side Effects:
- Adherence:
- Burden:
-
arkk stopped taking the treatment Tysabri • Jan 30, 2012- Stopped treatment
- Tysabri
- Stopped: Sep 15, 2011
- Reason: Doctor's advice and Other
-
arkk added the treatment Gilenya • Jan 30, 2012- Added treatment
- Gilenya
- Started: Jan 11, 2012
- Dosage: 0.5 mg daily
- Purpose: MS (Multiple Sclerosis)
-
arkk completed the MSRS survey for Jan 2, 2012 • Jan 02, 2012- MSRS
- 50
- Cognition
- Vision
- Speech
- Swallowing
- Upper Limb
- Walking
- Sensation
-
arkk added the treatment Interferon beta-1a SubQ injection • Dec 04, 2011- Added treatment
- Interferon beta-1a SubQ injection
- Started: ?
- Purpose: MS (Multiple Sclerosis)
-
arkk added the condition Bipolar Disorder • Nov 02, 2011- Added condition
- Bipolar Disorder
- First symptom: ?
- Diagnosis: ?
-
-
arkk added an InstantMe for Jan 25, 2011 • Jan 25, 2011 6:55AM- InstantMe
- Neutral
miserable weather outside, feeling bored.
-




